Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Gottlieb

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
BMJ (Clinical Research Ed.)|May 8, 2002
Drug companies maintain "astounding" profitsScott Gottlieb
American Health & Drug Benefits|February 5, 2020
Don't Give Up on Biosimilars-Congress Can Give Them a Boost: Drugs grown in live cells are hard to replicate. But policy changes can help accelerate the processScott Gottlieb
Missouri Medicine|March 12, 2020
Pot Legalization Makes Vaping DeadlyScott Gottlieb
Health Affairs (Project Hope)|May 9, 2007
Drug safety proposals and the intrusion of federal regulation into patient freedom and medical practiceScott Gottlieb
JAMA Health Forum|October 11, 2022
The Need for a US National Clinical Trial Infrastructure in a Public Health CrisisScott Gottlieb
JAMA Health Forum|October 11, 2022
Evaluating Postmarket Vaccine Safety-Time to Consolidate This Mission at a Single AgencyScott Gottlieb
Journal of Oncology Practice|July 20, 2014
Culture of how Washington pays for medical careScott Gottlieb
BMJ (Clinical Research Ed.)|June 14, 2003
Survival after partial lung transplants is as good as after full lung transplantsScott Gottlieb
BMJ (Clinical Research Ed.)|February 6, 2009
Relationships with the drug industry: Build trust based on good scienceScott Gottlieb
BMJ (Clinical Research Ed.)|May 25, 2004
New York's war on tobacco produces record fall in smokingScott Gottlieb
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
BMJ (Clinical Research Ed.)|May 8, 2002
Drug companies maintain "astounding" profitsScott Gottlieb
American Health & Drug Benefits|February 5, 2020
Don't Give Up on Biosimilars-Congress Can Give Them a Boost: Drugs grown in live cells are hard to replicate. But policy changes can help accelerate the processScott Gottlieb
Missouri Medicine|March 12, 2020
Pot Legalization Makes Vaping DeadlyScott Gottlieb
Health Affairs (Project Hope)|May 9, 2007
Drug safety proposals and the intrusion of federal regulation into patient freedom and medical practiceScott Gottlieb
JAMA Health Forum|October 11, 2022
The Need for a US National Clinical Trial Infrastructure in a Public Health CrisisScott Gottlieb
JAMA Health Forum|October 11, 2022
Evaluating Postmarket Vaccine Safety-Time to Consolidate This Mission at a Single AgencyScott Gottlieb
Journal of Oncology Practice|July 20, 2014
Culture of how Washington pays for medical careScott Gottlieb
BMJ (Clinical Research Ed.)|June 14, 2003
Survival after partial lung transplants is as good as after full lung transplantsScott Gottlieb
BMJ (Clinical Research Ed.)|February 6, 2009
Relationships with the drug industry: Build trust based on good scienceScott Gottlieb
BMJ (Clinical Research Ed.)|May 25, 2004
New York's war on tobacco produces record fall in smokingScott Gottlieb
Pageof 9